Breast cancer returning 21 years later as a solitary parotid metastasis
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Invasive Lobular Carcinoma
- Biomarkers
- Parotid metastasis ER positive (Q score 8); PR positive (Q score 6–7); HER2 borderline by IHC but FISH 1.82, regarded as negative
- Sex
- Female
- Spread to
- left parotid gland
- Treatment
- surgery, radiation, chemotherapy and hormone therapy
- Outcome
- Living With Cancer
Treatment course, step by step
- Underwent wide local excision of the left breast 26 years earlier.
- Received radiation to the breast, axilla and supraclavicular fossa.
- After local recurrence 5 years later, underwent completion mastectomy and axillary clearance.
- Completed 6 cycles of cyclophosphamide, methotrexate and fluorouracil.
- Took tamoxifen for 8 years.
- Started an aromatase inhibitor for the solitary parotid metastasis.
- Radiation to the parotid was considered but not given because the tumour responded to endocrine therapy.
What happened, in summary
A 71-year-old woman presented with several months of gradual swelling in the left parotid gland and a 2 × 2 cm hard lump. Her breast-cancer history stretched back 26 years, when she underwent wide local excision for left invasive ductal carcinoma followed by radiation to the breast, axilla and supraclavicular area.
Five years after that first treatment, the cancer recurred locally with axillary-node involvement. She then underwent completion mastectomy and axillary clearance, followed by 6 cycles of cyclophosphamide, methotrexate and fluorouracil and 8 years of tamoxifen.
Biopsy of the new parotid lesion showed adenocarcinoma with mixed ductal and lobular features consistent with metastatic breast cancer. The metastasis was ER positive and PR positive; HER2 testing was ultimately regarded as negative by FISH. PET-CT showed uptake only in the left parotid lesion, and a bone scan found no other metastatic disease.
Because the parotid lesion represented distant recurrence, her latest breast-cancer stage was Stage IV. She started an aromatase inhibitor. Radiation was considered but not used because the tumour was responding to endocrine treatment. On follow-up, the parotid mass became slightly smaller. More than 5 months after the metastatic diagnosis, her disease remained stable on endocrine therapy.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Breast Cancer 295 stories
- Stage 4 ER Positive Breast Cancer 87 stories
- ER Positive Breast Cancer 242 stories
- Chemotherapy for ER Positive Breast Cancer 143 stories
- Chemotherapy for Breast Cancer 726 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer